je.st
news
Mylan skeptical of rumored Teva bid; hasn't received offer
2015-04-17 22:51:44| Biotech - Topix.net
Generic drugmaker Mylan, citing media speculation that Teva Pharmaceutical may be eyeing it as a takeover target, says it doubts that regulators would approve such a deal and says it is committed to its current strategy as a stand-alone company. In a news release Friday, Mylan said that it hasn't received an offer and described the idea that Teva might want to buy it as a rumor.
Tags: offer
received
bid
skeptical
Category:Biotechnology and Pharmaceuticals